Filing Details
- Accession Number:
- 0001104659-21-099741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-04 06:06:25
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-04 06:06:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1790340 | Immuneering Corp | IMRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1870062 | J. Benjamin Zeskind | C/O Immuneering Corporation, 245 Main Street, Second Floor Cambridge MA 02142 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-08-03 | 49,099 | $0.00 | 2,598,171 | No | 4 | C | Direct | |
Class A Common Stock | Acquisiton | 2021-08-03 | 2,098 | $15.00 | 2,600,269 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Series A Preferred Stock | Disposition | 2021-08-03 | 40,928 | $0.00 | 40,928 | $0.00 |
Class A Common Stock | Series B Preferred Stock | Disposition | 2021-08-03 | 8,171 | $0.00 | 8,171 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 544,927 | Indirect | See Foonote |
Footnotes
- Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
- Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.